Symmetry Medical is a publicly traded company trading on XNYS, led by CEO H. Michael Schwartz, with a market cap of $1.8B.
Common questions about Symmetry Medical
Symmetry Medical is scheduled to report earnings for Q1 2026 on May 6, 2026 after market close. Analysts estimate revenue of $61.8M.
We use cookies for analytics. See our Privacy and Cookie Policy.